Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer

Table 3 Survival and DTH Responses

Patient	Survival from initiation of vaccine	DTH response	IL-12p70 Production (pg/mL)
1	27 months	No Reaction	931
2	9 months	No Reaction	N/A
3	7 months	Positive at week 6 to KLH	2067
4	22 months	Positive at weeks 6 and 14 to KLH	N/A
5	15 months	No Reaction	341
6	13 months	No Reaction	1134
7	> 90 months^a	No Reaction	N/A
8	28 months	No Reaction	1714
9	50 months	No Reaction	3937